The prospective use of Brazilian marine macroalgae in Schistosomiasis control

Butantan affiliation
Publication type
Access rights
Open access
Terms of use
Appears in Collections:
Schistosomiasis is a parasitic disease that affects more than 250 million people. The treatment is limited to praziquantel and the control of the intermediate host with the highly toxic molluscicidal niclosamide. Marine algae are a poorly explored and promising alternative that can provide lead compounds, and the use of multivariate analysis could contribute to quicker discovery. As part of our search for new natural compounds with which to control schistosomiasis, we screened 45 crude extracts obtained from 37 Brazilian seaweed species for their molluscicidal activity against Biomphalaria glabrata embryos and schistosomicidal activities against Schistosoma mansoni. Two sets of extracts were taxonomically grouped for metabolomic analysis. The extracts were analyzed by GC–MS, and the data were subjected to Pattern Hunter and Pearson correlation tests. Overall, 22 species (60%) showed activity in at least one of the two models. Multivariate analysis pointed towards 3 hits against B. glabrata veliger embryos in the Laurencia/Laurenciella set, 5 hits against B. glabrata blastula embryos, and 31 against S. mansoni in the Ochrophyta set. Preliminary annotations suggested some compounds such as triquinane alcohols, prenylated guaianes, dichotomanes, and xenianes. Despite the putative identification, this work presents potential candidates and can guide future isolation and identification
Stein EM., Tajú SG, Miyasato PA, Freitas RP, Tallarico LF, Santos GS., et al. The prospective use of Brazilian marine macroalgae in Schistosomiasis control. Marine Drugs. 2021 Apr;19(5):234. doi:10.3390/md19050234.
Link to cite this reference
Journal title
Issue Date

Files in This Item:

Size: 1.93 MB
Format: Adobe PDF
Show full item record

This item is licensed under a Creative Commons License Creative Commons